Ann: Medlab Signs CRO for NanaBis Phase III Trial, page-4

So cheap. Has been pushed down in purpose to create doubt. All due to the sophisticated and institutional placements and selling down so when it returns to the low if 30c its 100% increase from now and in hope more sellers come out thinking its gone up heaps. All part if sp manipulatiin.... all imo. True value right now is 1$ per share but is down at -90% after all positive announcements and trials.. usually would be down 90% if those trials failed and bad news flow. Which makes no sense and is why it will probably to an a2m when they are ready for it.